Abstract: The present invention provides a peptide marker targeting to nasopharyngeal carcinoma (NPC) cells and application thereof. The peptide binds specifically to the cell surface of NPC cells. After conjugated with liposome containing chemotherapeutic drugs, such peptides deliver chemotherapeutic drugs to the tumor cells specifically and destruct tumor cells without damaging normal tissues and organs. Furthermore, such peptide is applied as a detector in the development of NPC diagnosis kit.
Type:
Grant
Filed:
March 9, 2004
Date of Patent:
July 3, 2007
Assignee:
National Taiwan University
Inventors:
Han-Chung Wu, Chin-Tarng Lin, Tong-Young Lee